| abstract |
The present invention relates to compounds that are inhibitors of the enzyme dipeptidylpeptidase-IV ("DP-IV inhibitors") and that are useful in the treatment or prevention of diseases in which the enzyme dipeptidylpeptidase-IV is involved, such such as diabetes and particularly type 2 diabetes; The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of said diseases in which the enzyme dipeptidylpeptidase-IV is involved. |